Multisystem Processes & Disorders

Necrotizing fasciitis: recognition and surgical urgency

Clinical Overview and When to Suspect Necrotizing Fasciitis

— Type I (polymicrobial): mixed aerobes/anaerobes (Streptococci, Enterobacterales, Bacteroides, Clostridium); diabetics, post-op abdomen/perineum, Fournier gangrene.

— Type II (monomicrobial): Group A Streptococcus (GAS) ± Staph aureus including MRSA; healthy young adults after minor trauma, IVDU, varicella.

— Type III: Vibrio vulnificus (saltwater exposure, raw oysters, cirrhotics) and Aeromonas hydrophila (freshwater).

— Type IV: fungal (Mucor, Candida) — immunocompromised, trauma with soil contamination.

Board pearl: If a stem describes severe pain, tachycardia, and "cellulitis not responding to IV antibiotics" within 24–48 hours of admission — suspect NF and call surgery before re-imaging. Imaging delays kill.

Step 3 management: The correct next step in any suspected NF case is emergent surgical consultation for operative exploration, not CT, not MRI, not blood cultures alone.

Necrotizing fasciitis (NF) is a rapidly progressive soft-tissue infection of the deep fascia and subcutaneous tissue with secondary skin necrosis, vascular thrombosis, and systemic toxicity.

Mortality is 20–40% overall and approaches 70–100% when surgical debridement is delayed beyond 24 hours — time-to-OR is the single strongest modifiable predictor of survival.

Classification (memorize for boards):

Classic high-risk hosts: diabetes mellitus, cirrhosis, ESRD, malignancy, IVDU, recent surgery, obesity, immunosuppression, peripheral vascular disease, and any breach of skin (insect bite, IM injection, perineal trauma).

Pain out of proportion to exam in a febrile, ill-appearing patient is the cardinal early sign — often before skin changes manifest. This is the most tested concept on Step 3.

Early cutaneous findings are deceptively benign: erythema, warmth, induration mimicking cellulitis. Late findings (bullae, ecchymosis, crepitus, skin anesthesia, dishwater-gray drainage) indicate advanced disease and should never be awaited before surgical consultation.

Presentation Patterns and Key History

— Extremities (lower > upper): most common site overall, often Type II GAS in young healthy adults after minor trauma, sports injury, or IM injection.

— Perineum/scrotum (Fournier gangrene): Type I polymicrobial; diabetic or immunocompromised male, perirectal abscess or urethral instrumentation.

— Abdominal wall: post-operative, particularly after bowel surgery or in diabetic patients with bowel perforation.

— Head/neck (Ludwig angina, cervical NF): dental/odontogenic source; airway emergency.

— Truncal/saltwater wound: Vibrio in cirrhotic patient who ate raw oysters or waded in Gulf waters.

— Recent trauma, surgery, injection, insect bite, varicella in children.

— Diabetes, cirrhosis, immunosuppression, chemotherapy, chronic steroids.

— NSAID use (may mask early signs and is epidemiologically associated with severe GAS).

— Water exposure, seafood ingestion, soil contamination.

— IVDU including "skin popping."

Key distinction: Cellulitis pain is mild-moderate and confined to erythema; NF pain is severe, extends beyond visible changes, and worsens despite appropriate IV antibiotics within 24–48h.

Board pearl: Varicella + GAS = classic pediatric NF stem. Cirrhotic + raw oysters = Vibrio. Diabetic + perineal pain = Fournier.

Time course: symptoms typically progress over hours, not days. A patient who looked "fine" yesterday now appears septic — that tempo is the hallmark.

Initial complaints are often nonspecific: localized pain, low-grade fever, malaise, flu-like syndrome. The pain is disproportionate to visible findings and may extend beyond areas of erythema.

Anatomic patterns to recognize on the exam:

Critical history elements to elicit:

Pain quality: severe, deep, often described as burning or throbbing; later replaced by anesthesia as cutaneous nerves are destroyed — a late, ominous finding.

Systemic symptoms: rigors, nausea, vomiting, diarrhea, confusion, oliguria — features of streptococcal toxic shock syndrome (STSS) in Type II NF.

Physical Exam Findings and Hemodynamic Assessment

— Erythema, warmth, edema, tenderness.

— Edema extending beyond the area of erythema is suspicious.

— Woody, tense induration (peau d'orange) rather than soft pitting edema.

— Tense bullae (clear or hemorrhagic).

— Dusky violaceous or gray discoloration.

— Skin pallor between erythematous patches ("dirty" mottling).

— Hemorrhagic bullae, frank skin necrosis, ecchymosis.

— Cutaneous anesthesia from nerve infarction.

— Crepitus (gas-forming organisms, esp. Clostridium, mixed Type I).

— "Dishwater" gray, foul, thin drainage on incision.

— Rapid advancement of margin over hours.

— Tachycardia and hypotension out of proportion to apparent skin findings — early shock.

— Fever may be absent in elderly, diabetics, immunosuppressed; hypothermia is an ominous sign.

— Altered mental status, oliguria, mottling, elevated lactate, prolonged capillary refill.

— Apply qSOFA / sepsis-3 criteria; most NF patients meet criteria for septic shock by ED arrival.

Step 3 management: Initiate two large-bore IVs, crystalloid 30 mL/kg, broad-spectrum antibiotics within 1 hour, and concurrent surgical consult — do not delay resuscitation for imaging.

Board pearl: Pain → anesthesia transition in the affected area is pathognomonic and a surgical emergency.

Examine the affected area carefully and serially; mark the leading edge of erythema with a skin marker and reassess every 30–60 minutes. Rapid advancement (cm/hour) is diagnostic of necrotizing infection.

Early findings (often mistaken for cellulitis):

Intermediate findings:

Late/ominous findings (do not wait for these):

Hemodynamic assessment:

Bedside maneuver: gentle probing of bullae or incision may reveal lack of resistance through fascia ("finger test" historically positive when subcutaneous tissue dissects easily off fascia with a gloved finger — performed by surgeon, not in ED).

Diagnostic Workup — Initial Labs, Imaging, and Biomarkers

— CBC with differential (leukocytosis with left shift; bandemia).

— Comprehensive metabolic panel (hyponatremia <135 is classic; AKI; transaminitis).

— Glucose (often elevated, even in non-diabetics, from stress).

— CRP (elevated, often >150 mg/L).

— Lactate, ABG/VBG (lactic acidosis signals shock).

— Creatine kinase (myonecrosis when markedly elevated).

— Coagulation panel (DIC common; INR, PTT, fibrinogen, D-dimer, platelets).

— Blood cultures × 2 before antibiotics if it does not delay therapy >45 min.

— Procalcitonin (supportive).

— Variables: CRP, WBC, hemoglobin, sodium, creatinine, glucose.

— ≥6 = intermediate risk; ≥8 = high risk.

— Sensitivity is only ~60–70%; a low LRINEC does NOT rule out NF. Use it only to raise suspicion, never to exclude.

— Plain radiograph: subcutaneous gas (specific but insensitive ~50%).

— CT with contrast: gas in soft tissues, fascial thickening, fat stranding, non-enhancing fascia, fluid tracking along fascial planes — high sensitivity (~80–90%).

— MRI: most sensitive but rarely practical; do not order in unstable patients.

— POCUS: subcutaneous edema, fluid along fascia (cobblestoning with deeper fluid).

Board pearl: Absence of soft-tissue gas does NOT rule out NF — GAS Type II rarely produces gas. Gas is more typical of polymicrobial Type I and clostridial infections.

Step 3 management: If clinical suspicion is high, page surgery before imaging. Imaging is for the stable, ambiguous patient — not the toxic one.

NF is a clinical diagnosis confirmed at operative exploration. Labs and imaging support but never delay surgery in a clinically suspicious case.

Initial labs to order on every suspected case:

LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis):

Imaging — only if patient is hemodynamically stable AND diagnosis is uncertain:

Diagnostic Workup — Advanced and Confirmatory Studies

— Gray, necrotic fascia that separates easily from underlying muscle.

— Lack of bleeding at fascial planes (vascular thrombosis).

— Thin, foul, "dishwater" pus.

— Loss of normal fascial resistance to blunt finger dissection.

— Frozen-section biopsy from fascial edge if diagnosis unclear (rarely needed).

— Tissue Gram stain and culture (aerobic and anaerobic) — superior to swab cultures.

— Fungal cultures if immunocompromised or trauma with soil contamination.

— Surgical pathology to document fascial necrosis and confirm diagnosis.

— Blood cultures × 2 (positive in ~60% of GAS NF).

— Asymmetric fascial thickening with fluid/gas tracking along fascial planes.

— Non-enhancement of fascia/muscle (vascular thrombosis).

— Subcutaneous emphysema.

— Abscess or organ source (perforation, abscess driving Type I disease).

— Vibrio vulnificus: classically in cirrhotic with thrombocytopenia and hemorrhagic bullae after saltwater contact — start doxycycline + ceftriaxone (or cefotaxime).

— Clostridial myonecrosis (gas gangrene): marked CK elevation, prominent gas, deep muscle pain, often post-traumatic or post-abortion.

Key distinction: Pyomyositis primarily involves muscle on imaging without fascial necrosis; NF centers on fascial involvement with secondary muscle/skin injury.

Board pearl: A hemodynamically unstable patient with suspected NF goes to the OR, not the CT scanner. This is the single highest-yield Step 3 testing point.

Operative exploration is the gold standard and the only definitive diagnostic test. Findings at surgery:

Microbiologic studies obtained intraoperatively:

CT findings to recognize (when imaging is appropriate):

MRI findings: T2 hyperintensity in deep fascia, non-enhancing fascia, peripheral enhancement; high sensitivity but specificity limited by overlap with non-necrotizing inflammation.

Differential laboratory clues:

Risk Stratification and First-Line Management Logic

— Track 1 — Resuscitation: 30 mL/kg balanced crystalloid bolus, norepinephrine titrated to MAP ≥65, central access, arterial line in unstable patients.

— Track 2 — Empiric antibiotics within 1 hour: broad-spectrum coverage including MRSA, gram-negatives, anaerobes, and antitoxin agent.

— Track 3 — Surgical consultation for emergent debridement: target time from presentation to OR <6 hours; ideally <3 hours.

— LRINEC ≥6: suspect NF.

— SOFA / qSOFA: identifies sepsis severity, drives ICU disposition.

— APACHE II ≥20 at admission predicts high mortality.

— Delay to surgery >24 hours.

— Age >60, diabetes, immunosuppression, cirrhosis.

— Lactate >6, WBC >30k, creatinine >2.

— Truncal or perineal involvement (harder to fully debride).

— Need for vasopressors at presentation.

Step 3 management: "Source control" in NF = wide surgical debridement. Antibiotics alone cannot cure NF because vascular thrombosis prevents drug delivery to the infected fascia.

Board pearl: Every additional 24-hour delay to surgical debridement roughly doubles mortality.

NF is treated as septic shock + surgical emergency simultaneously. Three parallel tracks must run concurrently:

CCS pearl: In a Step 3 CCS case of NF, the correct early order set includes: IV access × 2, NS bolus, CBC, CMP, lactate, blood cultures × 2, CRP, CK, coagulation panel, ABG, vancomycin, piperacillin-tazobactam, clindamycin, surgical consult — emergent, and NPO. Advancing the clock without surgical consult will cost points.

Risk stratification scores (supportive only):

Indicators of poor prognosis:

Disposition: ICU admission post-debridement, often with planned return to OR every 12–24h for re-exploration and serial debridement until viable tissue margins are achieved.

Pharmacotherapy — First-Line Empiric Antibiotic Regimen

— Broad gram-negative + anaerobic agent: piperacillin-tazobactam 4.5 g IV q6–8h, OR meropenem 1 g IV q8h, OR cefepime + metronidazole.

— MRSA coverage: vancomycin 25–30 mg/kg load then dose by trough (target 15–20), OR linezolid 600 mg IV q12h, OR daptomycin (not for pneumonia but fine for skin).

— Antitoxin/protein-synthesis inhibitor: clindamycin 900 mg IV q8h — suppresses exotoxin production by GAS and Clostridium (Eagle effect: clindamycin works on stationary-phase organisms when penicillin fails due to high inoculum).

Board pearl: Clindamycin is the antitoxin agent for GAS NF — its mechanism (ribosomal protein-synthesis inhibition) shuts down exotoxin and superantigen production responsible for STSS. Always include it empirically.

Key distinction: Antibiotics alone never cure NF; they are an adjunct to surgery.

Empiric triple therapy is standard until cultures and surgical findings refine coverage:

Once GAS confirmed: narrow to penicillin G 4 million units IV q4h + clindamycin (continue clindamycin for ≥48–72h or until clinical improvement and source control).

Linezolid alternative: increasingly favored over clindamycin where clindamycin resistance in GAS is rising (~10–15% in some US regions); also covers MRSA, eliminating need for vancomycin.

Type III — Vibrio vulnificus: doxycycline 100 mg IV/PO q12h + ceftriaxone 1–2 g IV q24h (or cefotaxime). Add to empiric regimen in any saltwater exposure or cirrhotic with rapidly progressive cellulitis.

Aeromonas (freshwater): doxycycline + ciprofloxacin or ceftriaxone.

Fungal NF: liposomal amphotericin B; surgical debridement is even more critical.

IVIG: consider 1 g/kg day 1 then 0.5 g/kg days 2–3 in streptococcal toxic shock syndrome with refractory hypotension; evidence is modest but recommended by IDSA in severe GAS infections.

Duration: continue IV antibiotics until no further debridement is needed, the patient is clinically improving, and ideally 48–72h afebrile; typically 10–14 days, longer if bacteremia.

Surgical Management — Source Control and Operative Strategy

— Wide debridement of all necrotic skin, subcutaneous tissue, and fascia until viable, bleeding tissue is reached.

— Margins extend well beyond visible necrosis because subcutaneous spread exceeds skin findings.

— Tissue sent for Gram stain, aerobic/anaerobic/fungal culture, and histopathology.

— Wounds are typically left open with wet-to-dry dressings or negative-pressure wound therapy after initial source control.

— Planned re-exploration every 12–24 hours until no further necrosis identified, often 3–5 trips to OR.

— Extremity: amputation may be necessary for fulminant disease or to control sepsis; counsel family but do not delay.

— Fournier gangrene: diverting colostomy may be needed if perineal/perianal involvement; suprapubic catheter for urinary diversion.

— Abdominal wall: address underlying intra-abdominal source (perforation, abscess).

— Cervical/Ludwig: secure airway early (awake fiberoptic intubation or tracheostomy); ENT involvement.

— Hyperbaric oxygen (HBO): theoretical benefit for clostridial and mixed infections; must not delay debridement. Evidence is limited; available only at select centers.

— IVIG: as above for STSS.

— Reconstruction: skin grafts, flaps, and abdominal wall reconstruction in survivors, typically weeks later after wound stabilization.

CCS pearl: In a CCS NF case, the precise order is "Surgery consult, STAT — emergent debridement" within the first sim-minutes; if you order CT first on an unstable patient, expect score deductions.

Board pearl: Adequacy of initial debridement is the strongest predictor of survival — under-debridement, not antibiotic choice, is the typical failure mode.

Emergent surgical debridement is the cornerstone and the only intervention that meaningfully reduces mortality. Target door-to-OR <6 hours.

Operative principles:

Anatomic considerations:

Adjunctive therapies:

Multidisciplinary team: trauma/general surgery, plastics, infectious disease, critical care, urology (Fournier), ENT (cervical), wound care, physical/occupational therapy, social work.

Special Populations — Elderly and Renal/Hepatic Impairment

— Often present atypically: minimal fever, blunted leukocytosis, vague pain, delirium as the dominant complaint.

— Lower threshold for surgical exploration; mortality approaches 50–60% in patients >70.

— Polypharmacy (NSAIDs, anticoagulants) complicates surgery and may mask early signs.

— Pre-existing PVD, diabetes, and CKD compound risk.

— Strict glycemic control intraoperatively and in ICU (target 140–180 mg/dL).

— Watch for euglycemic DKA with SGLT2 inhibitors — hold them peri-operatively.

— Higher rates of polymicrobial Type I disease, Fournier gangrene, and post-debridement wound healing complications.

— Particularly high risk for Vibrio vulnificus NF after raw oyster ingestion or saltwater wound — empirically cover with doxycycline + ceftriaxone.

— Coagulopathy (elevated INR, thrombocytopenia) complicates surgery; transfuse FFP, platelets, cryoprecipitate as needed but do not delay debridement for "correcting" INR.

— Higher mortality (>50%); MELD score predicts outcome.

— Dose-adjust piperacillin-tazobactam, vancomycin, meropenem; clindamycin and linezolid do not require renal adjustment.

— Vancomycin trough monitoring critical; AUC-guided dosing preferred.

— Avoid nephrotoxic combinations where possible; volume status balance challenging in dialysis patients.

— Higher risk of fungal NF (Mucor, Candida) — add empiric antifungal if rapidly progressing despite antibiotics.

— Atypical organisms (Pseudomonas, atypical mycobacteria) may require expanded coverage.

Step 3 management: In ESRD on hemodialysis with NF, give full loading doses of antibiotics first, then renal-adjust subsequent doses — under-dosing the first dose costs lives.

Board pearl: Cirrhotic + hemorrhagic bullae + saltwater = Vibrio vulnificus until proven otherwise. Mortality >50%; doxycycline + ceftriaxone empirically.

Elderly patients:

Diabetes mellitus (the single most common comorbidity in NF):

Cirrhosis:

Chronic kidney disease / ESRD:

Immunocompromised (chemotherapy, transplant, HIV with low CD4, chronic steroids):

Special Populations — Pregnancy, Pediatrics, and Postpartum

— NF is rare but devastating in pregnancy; can complicate cesarean wounds, episiotomy sites, or perineal tears.

— Postpartum streptococcal toxic shock with uterine/abdominal wall NF — classic GAS scenario.

— Imaging: MRI preferred over CT to minimize fetal radiation if stable; do not delay surgery for imaging in unstable patients.

— Safe antibiotics: penicillin, cephalosporins, clindamycin, vancomycin. Avoid tetracyclines (use only if Vibrio strongly suspected and benefit outweighs risk) and fluoroquinolones when alternatives exist.

— Maternal stabilization takes priority; delivery decisions individualized with OB.

— Varicella + GAS is the classic stem — sudden worsening of pain at a chickenpox lesion with fever; vaccination has decreased but not eliminated incidence.

— Omphalitis-associated NF in neonates — abdominal wall erythema with foul drainage from umbilical stump.

— Perineal NF after circumcision or in infants with diaper dermatitis superinfection.

— Antibiotic dosing weight-based; pediatric surgery and PICU involvement essential.

— IVIG more commonly used in pediatric STSS.

— "Skin popping," contaminated drug supply (especially black tar heroin → clostridial NF), and shared needles.

— Expect MRSA, Pseudomonas, and clostridial coverage; screen for HIV, HCV, HBV, endocarditis.

— Pain control challenging; involve addiction medicine and offer MOUD (methadone, buprenorphine) during admission.

— NF after abdominal, gynecologic, or perineal surgery — Type I polymicrobial; consider bowel anastomotic leak as source.

Board pearl: A previously well child with chickenpox who develops worsening pain, fever, and erythema at a vesicular lesion has GAS NF until proven otherwise — emergent surgical consult.

Key distinction: Postpartum endometritis with abdominal wall pain progressing rapidly = consider NF, not just wound infection.

Pregnancy:

Pediatrics:

IV drug users:

Post-operative patients:

Complications and Adverse Outcomes

— Defined by GAS isolation + hypotension + ≥2 of: AKI, coagulopathy, hepatic involvement, ARDS, generalized erythematous macular rash, soft tissue necrosis.

— Mortality 30–70% even with optimal therapy.

— Treat with clindamycin + penicillin + IVIG + aggressive source control.

Step 3 management: All NF survivors require DVT prophylaxis (mechanical initially, pharmacologic once hemostasis allows), glycemic control, early enteral nutrition, and early PT/OT consultation in ICU.

Board pearl: Refractory hypotension in GAS NF despite vasopressors and source control → consider IVIG 1 g/kg to neutralize superantigens.

Streptococcal Toxic Shock Syndrome (STSS):

Sepsis and septic shock: nearly universal at presentation; multi-organ failure common.

DIC: from systemic inflammation and tissue factor release; manage with FFP, cryoprecipitate, platelets, RBCs as needed.

Acute kidney injury: from shock, rhabdomyolysis, contrast (avoid if possible), nephrotoxic antibiotics; may need CRRT.

ARDS: high incidence in septic NF; lung-protective ventilation (6 mL/kg ideal body weight, plateau <30).

Rhabdomyolysis: from myonecrosis; CK often >10,000; aggressive IV fluids, monitor potassium.

Limb loss: 15–30% of extremity NF require amputation; functional rehabilitation prolonged.

Massive tissue loss and disfigurement: requires skin grafts, flaps, and reconstruction over months; psychological morbidity high.

Critical illness myopathy/neuropathy and ICU delirium: from prolonged ventilation, sedation, paralytics.

Hospital-acquired complications: VTE (start prophylaxis when surgically safe), catheter-associated infections, pressure ulcers, C. difficile from broad antibiotics, stress ulcer (PPI prophylaxis if intubated/coagulopathic).

Mortality: overall 20–40%; Vibrio ~50%; Fournier ~20–40%; cervical NF ~30%; doubles with each 24h surgical delay.

Long-term sequelae: chronic pain, neuropathic pain, lymphedema, post-traumatic stress, depression, functional impairment, return-to-work limitations.

When to Escalate Care — ICU, Consults, and Transfer

— Septic shock requiring vasopressors.

— Mechanical ventilation (for shock, ARDS, or post-op).

— Multi-organ failure, DIC, AKI requiring CRRT.

— Need for repeated operative debridement with frequent hemodynamic monitoring.

— Surgery (general/trauma, urology for Fournier, ENT for cervical, OB-GYN for postpartum) — emergent.

— Infectious disease — antibiotic stewardship, source identification, IVIG decisions.

— Critical care — admission and resuscitation.

— Plastic surgery — early for reconstruction planning, especially extensive truncal/extremity disease.

— Anesthesia — airway and OR readiness.

— Community hospitals lacking 24/7 surgical coverage, ICU capability, or wound care must transfer after initial resuscitation and antibiotic administration, not before.

— Do not transfer to obtain imaging — go to OR locally if surgery is available.

— Hyperbaric oxygen centers may be considered but only after definitive debridement, not in place of it.

— Direct physician-to-physician handoff with explicit articulation of NF diagnosis, antibiotics administered, and time-critical nature.

— Family conversations early regarding mortality risk, possible amputation, and prolonged ICU/rehabilitation course.

CCS pearl: In a CCS sim with limited resources, the order sequence is: resuscitate → antibiotics → surgery consult → ICU admit → consider transfer only if local OR/ICU unavailable.

Board pearl: Never transfer an NF patient to "get a CT" at another facility — that delay is independently associated with mortality. If surgery is available locally, operate locally first.

ICU admission is mandatory for essentially all confirmed NF cases:

Consultations to obtain in the first hour:

Transfer considerations:

EMTALA considerations: emergency stabilization (IV access, antibiotics, fluid resuscitation, surgical consultation attempt) before transfer; document medical necessity for transfer if local surgical resources unavailable.

Communication:

Key Differentials — Same-Category Soft-Tissue Infections

— Erythema, warmth, tenderness limited to dermis/superficial subcutaneous tissue.

— Pain proportional to exam; no rapid progression; usually responds to outpatient antibiotics or inpatient cefazolin/vancomycin.

— No systemic toxicity in most cases.

— Sharply demarcated, raised, bright red plaque (vs. ill-defined cellulitis); often face/legs.

— Usually Streptococcus pyogenes; responds to penicillin/cefazolin.

— Systemic symptoms milder; no necrosis.

— Fluctuant, localized; incision and drainage is the primary treatment.

— Often MRSA; adjunctive TMP-SMX or doxycycline if systemic symptoms or surrounding cellulitis.

— Primary bacterial infection of skeletal muscle, often Staph aureus; tropical exposure, IVDU, immunocompromised.

— Imaging shows intramuscular abscess without fascial necrosis.

— Treatment: drainage + antistaphylococcal antibiotics.

— A subset of necrotizing soft-tissue infection; Clostridium perfringens; deep muscle pain, marked gas on imaging, often post-traumatic or post-surgical.

— Treatment overlaps with NF: emergent debridement + penicillin + clindamycin.

— Subset where infection is largely superficial subcutaneous tissue without deep fascia involvement; still requires aggressive debridement.

Key distinction: Pain disproportionate to exam, rapid spread, systemic toxicity, and failure to improve on appropriate IV antibiotics within 24h distinguishes NF from cellulitis. When in doubt, surgical exploration is the answer.

Board pearl: Cellulitis that "isn't getting better" or "looks worse despite IV vancomycin/cefazolin" in 24 hours is NF until exploration proves otherwise.

Cellulitis (non-purulent or purulent):

Erysipelas:

Cutaneous abscess:

Pyomyositis:

Clostridial myonecrosis (gas gangrene):

Necrotizing cellulitis:

Septic bursitis or septic arthritis: localized to joint/bursa; arthrocentesis diagnostic.

Key Differentials — Non-Infectious and Other Mimics

— Unilateral leg swelling, pain, warmth; no fever or systemic toxicity.

— D-dimer, duplex ultrasound; anticoagulation, not surgery.

— Can coexist with NF; do not anchor on either diagnosis prematurely.

— Pain out of proportion (overlapping feature!), tense compartment, pain with passive stretch, paresthesia, pulselessness late.

— History of trauma, fracture, reperfusion injury, prolonged immobilization.

— Diagnosis: compartment pressure measurement (>30 mmHg or delta <30); fasciotomy is the treatment.

— Can also coexist with NF — surgical exploration addresses both.

— 6 P's: pain, pallor, paresthesia, pulselessness, poikilothermia, paralysis.

— Embolic (AF) or thrombotic; emergent vascular surgery, anticoagulation, revascularization.

— ESRD patients on dialysis with painful violaceous skin lesions progressing to necrosis.

— Treatment: sodium thiosulfate, address calcium/phosphate, wound care; not primarily surgical.

— Rapidly progressive painful ulcer with violaceous undermined border; associated with IBD, RA.

— Diagnosis of exclusion; treated with steroids/immunosuppression; debridement worsens it (pathergy) — important not to misdiagnose as NF.

Key distinction: Pyoderma gangrenosum improves with immunosuppression and worsens with surgery — the opposite of NF. Always ask about IBD/RA and look for the characteristic violaceous undermined border before incising.

Board pearl: When the clinical picture is ambiguous and patient is stable, MRI + dermatology/surgical consult helps separate NF from inflammatory mimics — but err on the side of surgical exploration when uncertain and toxic.

Deep vein thrombosis (DVT):

Compartment syndrome:

Acute limb ischemia:

Calciphylaxis:

Pyoderma gangrenosum:

Warfarin-induced skin necrosis: protein C deficiency; days after warfarin start; truncal/breast/fatty areas.

Brown recluse spider bite, ergotism, calcific uremic arteriolopathy: rare mimics.

Severe contact dermatitis or fixed drug eruption: usually no systemic toxicity, history clarifies.

Secondary Prevention, Discharge Planning, and Long-Term Care

— Wound care with NPWT (wound vac) or staged dressings.

— Serial debridements as needed; reconstruction (skin grafts, flaps) once wound bed is stable.

— Transition from IV to oral antibiotics once source controlled, afebrile 48–72h, clinically improving; total duration individualized but commonly 2–4 weeks.

— Tailored oral antibiotic regimen based on culture data (often amoxicillin-clavulanate, doxycycline, or linezolid for select organisms).

— Pain control with multimodal approach: acetaminophen, gabapentin/pregabalin for neuropathic pain, judicious opioids with explicit taper plan.

— VTE prophylaxis continued if mobility limited.

— Diabetic medications optimized; insulin commonly required during convalescence.

— Wound care supplies and home health nursing if NPWT continued at home.

— Diabetes: A1c target individualized, foot care education, podiatry referral.

— Cirrhosis: strict avoidance of raw oysters/seafood and saltwater exposure for Vibrio prevention; counsel explicitly at discharge.

— IVDU: link to MOUD, syringe-service programs, harm reduction.

— Vaccinations: ensure varicella, influenza, pneumococcal, COVID-19 status current; tetanus booster if wound-related.

— Skin/wound hygiene; prompt evaluation of new soft-tissue infections.

— Inpatient rehab for amputees and large debridements.

— Prosthetic fitting at 6–12 weeks post-amputation as stump matures.

— Lymphedema management with compression and PT.

Step 3 management: At discharge, cirrhotic NF survivors must receive explicit counseling to avoid raw shellfish and saltwater wounds — document in chart. This is a high-yield Step 3 prevention pearl.

Board pearl: Tetanus booster status should be checked and updated for any NF survivor with a wound-related etiology before discharge.

Post-acute hospital course:

Discharge medications:

Secondary prevention:

Functional rehabilitation:

Follow-Up, Monitoring, and Rehabilitation

— Surgery: 1–2 weeks post-discharge for wound assessment, every 2–4 weeks thereafter until wound closure or reconstruction.

— Infectious disease: 2–4 weeks post-discharge to finalize antibiotic duration and assess for recurrence.

— Primary care: within 1 week of discharge — medication reconciliation, comorbidity management, screen for depression/PTSD.

— Plastics: at intervals for staged reconstruction.

— Specialty as indicated: endocrinology (diabetes), hepatology (cirrhosis), addiction medicine (IVDU), urology (Fournier follow-up including colostomy reversal in 3–6 months).

— Wound healing, signs of recurrent infection (erythema, drainage, fever).

— CBC, CMP, CRP trending downward.

— A1c every 3 months in diabetics.

— Renal function if persistent AKI or nephrotoxic antibiotics.

— Mental health screening (PHQ-9, GAD-7, PCL-5 for PTSD).

— Physical therapy: strength, range of motion, gait training.

— Occupational therapy: ADLs, return-to-work planning.

— Prosthetics for amputees; lymphedema therapy.

— Speech therapy if cervical NF affected swallowing.

— Sexual function and intimacy counseling for Fournier survivors.

— Post-ICU syndrome (cognitive, psychiatric, physical) is common after NF given prolonged ICU stays.

— PTSD rates elevated; refer to behavioral health early.

— Peer support groups for amputees and burn-like survivors helpful.

— Detailed discharge summary to all outpatient providers.

— Home health, wound care supplies, durable medical equipment arranged before discharge.

Step 3 management: Schedule the first surgical wound check within 7–10 days of discharge; gaps in follow-up are a major cause of readmission for wound complications.

Board pearl: Screen all NF survivors for depression and PTSD at the first post-discharge visit — these are prevalent and undertreated.

Follow-up cadence:

Monitoring parameters:

Rehabilitation focus:

Psychological care:

Documentation and care coordination:

Ethical, Legal, and Patient Safety Considerations

— Patients with septic NF are often delirious, intubated, or coagulopathic — unable to provide consent.

— Use two-physician emergency consent when life-or-limb threatening surgery is required and surrogate cannot be reached. Document attempts to contact next of kin.

— Once stable, discuss subsequent debridements, amputation, or reconstruction with the patient or properly identified surrogate following the state hierarchy (spouse → adult child → parent → adult sibling).

— Anticipate the need for early goals-of-care conversations: high mortality, possible amputation, prolonged ICU stay.

— Palliative care consultation appropriate even when pursuing aggressive care.

— Cultural and religious considerations for amputation (e.g., some patients request limb preservation/burial).

— Invasive Group A streptococcal disease (including STSS and NF) is a reportable condition in most US states — notify the local health department.

— Vibrio vulnificus infections are reportable.

— Suspected human bite or assault-related wound triggers domestic violence screening and possible mandatory reporting if a minor or dependent adult is involved.

— Highest-risk handoff is OR-to-ICU and ICU-to-floor — use structured handoffs (e.g., I-PASS) with explicit antibiotic schedule, planned re-operations, and unresolved issues.

— Medication reconciliation at every transition; broad-spectrum antibiotics increase risk of C. difficile, drug interactions, and dosing errors.

— Door-to-antibiotic and door-to-OR times are core quality metrics.

— Root cause analysis for missed or delayed NF diagnoses; "cellulitis not improving" should trigger re-examination protocols.

— Disclosure of medical error if delay in diagnosis occurred — transparent communication is both ethically required and protective.

Board pearl: Invasive GAS disease is reportable to public health — order this in your CCS case along with antibiotics.

Informed consent in the unstable patient:

Goals of care and limb-loss discussions:

Mandatory reporting and public health:

Transition-of-care safety:

Patient safety / quality:

High-Yield Associations and Rapid-Fire Clinical Facts

Step 3 management: Memorize the empiric triple regimen — vancomycin + piperacillin-tazobactam + clindamycin — it covers virtually all NF presentations until cultures refine therapy.

Board pearl: "Cellulitis not responding to IV antibiotics" is the most common Step 3 entry point for an NF question.

Pain out of proportion to exam + fever + ill appearance = NF until proven otherwise.

Clindamycin = antitoxin agent for GAS and Clostridium; suppresses exotoxin production via ribosomal blockade.

Eagle effect: at high inoculum, GAS enters stationary phase and is less susceptible to penicillin — clindamycin overcomes this.

Vibrio vulnificus = cirrhotic + raw oysters or saltwater wound + hemorrhagic bullae → doxycycline + ceftriaxone.

Aeromonas hydrophila = freshwater exposure → ceftriaxone + doxycycline (or ciprofloxacin).

Fournier gangrene = perineal/scrotal NF in diabetic men; polymicrobial; often colostomy + suprapubic catheter.

Ludwig angina = submandibular cervical NF; airway emergency; secure airway early.

Varicella + GAS = pediatric NF stem.

NSAIDs: epidemiologically linked to worse outcomes in GAS NF and may mask early signs; avoid in suspected NF.

LRINEC score: helpful when high, useless when low — does not rule out NF.

Soft-tissue gas on imaging: highly specific but only ~50% sensitive — absence does not exclude NF.

Mortality doubles with each 24-hour delay to surgical debridement.

STSS criteria: GAS isolated + hypotension + ≥2 organ involvement (renal, hepatic, coagulopathy, ARDS, rash, soft-tissue necrosis).

IVIG: 1 g/kg day 1, 0.5 g/kg days 2–3 for refractory STSS.

"Dishwater" pus at debridement = pathognomonic.

Finger test: easy blunt fascial dissection = positive surgical sign.

Hyponatremia <135 + leukocytosis + AKI in a "cellulitis" patient → suspect NF.

Type II (monomicrobial GAS) in healthy young adult after minor trauma → narrow to penicillin + clindamycin once confirmed.

HBO therapy: adjunctive only, never substitutes for surgical debridement.

Reportable: invasive GAS, Vibrio vulnificus.

Tetanus booster status update at discharge for all wound-related NF.

Board Question Stem Patterns

Board pearl: When a Step 3 stem describes any combination of "pain out of proportion," "rapidly progressive," "hemorrhagic bullae," "crepitus," or "cellulitis not responding," the answer involves emergent surgery somewhere in the answer choices.

Stem 1 — Classic Type II GAS NF: 28-year-old healthy man develops severe leg pain after a soccer injury 24 hours ago. T 39.5°C, HR 125, BP 88/50. Erythema with hemorrhagic bullae and exquisite tenderness extending beyond visible margins. WBC 22k, Na 131, Cr 1.8, lactate 4.2. Next step? → Emergent surgical consult for debridement (not CT, not MRI, not more antibiotics).

Stem 2 — Vibrio vulnificus: 58-year-old man with cirrhosis ate raw oysters yesterday; now febrile with rapidly progressive bullous lesions on the leg. Best empiric antibiotic? → Doxycycline + ceftriaxone (added to broad-spectrum coverage).

Stem 3 — Fournier gangrene: 65-year-old diabetic with perineal pain, scrotal swelling, crepitus. Next step? → Surgical consult for emergent debridement; broad-spectrum antibiotics (vancomycin + pip-tazo + clindamycin); ICU admission.

Stem 4 — Postpartum NF/STSS: postpartum day 3, abdominal wall erythema, hypotension, AKI, coagulopathy. GAS in blood. Adjunct beyond antibiotics? → IVIG and emergent debridement.

Stem 5 — Pediatric varicella + GAS: 6-year-old with chickenpox now febrile with rapidly worsening pain at a lesion. Diagnosis? → NF; next step → surgical consult.

Stem 6 — Cellulitis not improving: hospitalized patient on IV vancomycin + cefazolin for "cellulitis" worsens at 36h with bullae, anesthesia of the skin, and hypotension. Next step? → Surgical exploration, not antibiotic broadening.

Stem 7 — LRINEC trap: patient with classic NF features but LRINEC of 4. Action? → Proceed with surgical consultation regardless — LRINEC does not rule out NF.

Stem 8 — Antibiotic selection: which agent suppresses streptococcal toxin? Clindamycin (not vancomycin, not penicillin).

Stem 9 — Imaging timing: hypotensive patient with suspected NF. Best next step? → OR, not CT.

Stem 10 — Discharge counseling: cirrhotic NF survivor. What advice? → Avoid raw oysters and saltwater exposure for life.

One-Line Recap

Necrotizing fasciitis is a time-critical surgical emergency where rapid recognition of pain out of proportion to exam, immediate broad-spectrum antibiotics including clindamycin, and emergent operative debridement — not imaging — determine survival.

Board pearl: If you remember only one thing for Step 3: in a septic patient with "cellulitis not improving" or pain out of proportion, the next best step is emergent surgical consultation, not another imaging study, not another antibiotic. Cut, don't scan.

Recognition triad: severe pain out of proportion + systemic toxicity + rapidly progressive soft-tissue findings (bullae, crepitus, anesthesia, dusky skin) — even if the skin initially "just looks like cellulitis."

Empiric antibiotics within 1 hour: vancomycin (or linezolid) + piperacillin-tazobactam (or meropenem) + clindamycin; add doxycycline + ceftriaxone for cirrhotic/saltwater exposure (Vibrio); add IVIG for streptococcal toxic shock.

Source control is everything: emergent wide surgical debridement with planned re-exploration every 12–24h; antibiotics alone cannot cure NF because fascial vascular thrombosis blocks drug delivery — time-to-OR <6h, ideally <3h, with mortality roughly doubling for each 24-hour delay.

Disposition and follow-up: ICU admission, multidisciplinary team (surgery, ID, critical care, plastics, rehab), report invasive GAS and Vibrio to public health, screen survivors for PTSD/depression, and counsel cirrhotics to avoid raw shellfish and saltwater wounds permanently.